Â鶹ѧÉú¾«Æ·°æ

Journal Article

1. McDonald IR, Welt CK, Dwyer AA (2022). Health-related quality of life in women with primary ovarian insufficiency: a scoping review of the literature and implications for targeted interventions. Hum Reprod. ()
2. Sharma A, Krick B, Li Y, Summers SA, Playdon MC, Welt C (2022). The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS. J Endocr Soc, 6(11), bvac131. ()
3. Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, Lawlor DA, Laval G, Mathieson I, McCardle WL, Louwers Y, Meun C, Ring S, Scott RA, Sulem P, Uitterlinden AG, Wareham NJ, Thorsteinsdottir U, Welt C, Stefansson K, Laven JS, Ong KK, Perry JR (2015). Causal mechanisms and balancing selection inferred from genetic associations with the polycystic ovary syndrome. Nat Commun, 6, 8464-8470.
4. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, Azziz R, Zhang Y, James RG, Olivier M, Kissebah AH, Reproductive Medicine Network, Stener-Victorin E, Legro RS, Dunairf A (2015). Genomewide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun, 6, 7502-7514.
5. Saxena R, Bjonnes AC, Georgopoulos NA, Koika V, Panidis D, Welt CK (2015). Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Hum Reprod, 30, 1697-1703.
6. Pau CT, Keefe C, Duran J, Welt CK (2014). Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J Clin Endocrinol Metab, 99(5), 1870-8. ()
7. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 98(12), 4565-92. ()
8. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, Welt CK (2013). Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab, 98(9), E1534-9. ()
9. Saxena R, Welt CK (2013). Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol, 50(3), 451-7. ()
10. Welt CK, Styrkarsdottir U, Ehrmann DA, Thorleifsson G, Arason G, Gudmundsson JA, Ober C, Rosenfield RL, Saxena R, Thorsteinsdottir U, Crowley WF, Stefansson K (2012). Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab, 97(7), E1342-7. ()
11. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley WF Jr, Martin KA, Hall JE, Pitteloud N (2011). A genetic basis for functional hypothalamic amenorrhea. N Engl J Med, 364(3), 215-25. ()
12. Powe CE, Allen M, Puopolo KM, Merewood A, Worden S, Johnson LC, Fleischman A, Welt CK (2010). Recombinant human prolactin for the treatment of lactation insufficiency. Clin Endocrinol (Oxf), 73(5), 645-53. ()
13. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF (2006). Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab, 91(11), 4361-8. ()
14. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS (2004). Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med, 351(10), 987-97. ()

Review

1. Welt CK (2008). Primary ovarian insufficiency: a more accurate term for premature ovarian failure. [Review]. Clin Endocrinol (Oxf), 68(4), 499-509. ()

Case Report

1. Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P (2013). Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab, 98(10), 3920-5. ()
2. Welt CK, Falorni A, Taylor AE, Martin KA, Hall JE (2005). Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab, 90(5), 3069-76. ()

News

• Researchers Identify Genes Associated With Polycystic Ovary Syndrome
• New Hope for Women With PCOS
• Early Menopause Linked to Increased Breast Cancer Risk

Podcasts

• A New Understanding of PCOS
• Understand Breast Cancer's Link to Early Menopause